Sharon Begley is one of the top AD journalists out there IMO. She certainly isn't in any BP pocket, nor does she seem eager to tell anyone that will listen why every trial on the planet will fail like some in the industry have seemed want to do. Open minded and sees the real problem here.
Thanks Cyosol, The part about academia sticking to the Amyloid hypothesis because that was where the money was for research is telling. Makes you appreciate the Rockefeller family for establishing BRNI and Dr Alkon for going there to solve the real problem.
Also the part about BP management not taking any risks when academia was making excuses for every failed Amyloid trial shows how inbred the process is/was. I think the same is true for instutions investing in small bio companies going outside the Amyloid tract.